Drug Trial Radar · NCT07382908
Bioequivalence Study of BGM0504 Injection
Last checked: Nov 19, 2026Latest source record: Oct 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
144
Actual
Start
Dec 29, 2025
Primary completion
Apr 9, 2026
Study completion Apr 9, 2026
Sponsor
- Lead sponsor
- BrightGene Bio-Medical Technology Co., Ltd.Industry
- Sponsor type
- Industry
- First posted
- Feb 3, 2026
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 55 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a study to evaluate the bioequivalence of a single subcutaneous injection of BGM0504 multi-dose pen (experimental formula T1) and BGM0504 single-dose pen (experimental formula T2) with BGM0504 single-dose pen (reference formula R).
Conditions
- Overweight/Obesity
Interventions
BGM0504 Injection multi-dose penDrug
5 mg, single subcutaneous injection in the abdominal region
BGM0504 Injection single-dose penDrug
5 mg, single subcutaneous injection in the abdominal region
BGM0504 Injection single-dose penDrug
5 mg, single subcutaneous injection in the abdominal region
Primary outcomes
What the sponsor says the trial is designed to measure.
- Peak Plasma Concentration (Cmax)Time frame: 0 to 672 hours
- Area under the plasma concentration versus time curve (AUC)0-tTime frame: 0 to 672 hours
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Hangzhou First People's Hospital
Hangzhou, Zhejiang, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.